Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

Open access
Conley, Sarah J., Gheordunescu, Elizabeth, Kakarala, Pramod, Newman, Bryan, Korkaya, Hasan, Heath, Amber N., Clouthier, Shawn G., Wicha, Max S. · 2012 · Proceedings of the National Academy of Sciences

Abstract

Antiangiogenic therapy has been thought to hold significant potential for the treatment of cancer. However, the efficacy of such treatments, especially in breast cancer patients, has been called into question, as recent clinical trials reveal only limited effectiveness of antiangiogenic agents in prolonging patient survival. New research using preclinical models further suggests that antiangiogenic agents actually increase invasive and metastatic properties of breast cancer cells. We demonstrate that by generating intratumoral hypoxia in human breast cancer xenografts, the antiangiogenic agents sunitinib and bevacizumab increase the population of cancer stem cells. In vitro studies revealed that hypoxia-driven stem/progenitor cell enrichment is primarily mediated by hypoxia-inducible factor 1α. We further show that the Akt/β-catenin cancer stem cell regulatory pathway is activated in breast cancer cells under hypoxic conditions in vitro and in sunitinib-treated mouse xenografts. These studies demonstrate that hypoxia-driven cancer stem cell stimulation limits the effectiveness of antiangiogenic agents, and suggest that to improve patient outcome, these agents might have to be combined with cancer stem cell-targeting drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1018866109

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 698

Metadata

Authors
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S.
Affiliations
  • University of Michigan (US)
  • Comprehensive Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109
Venue
Proceedings of the National Academy of Sciences
Published
2012-01-23
Volume
109
Issue
8
Pages
2784-2789
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2044905529
Cited by
663
References
39
Citations by year
2026: 11 · 2025: 19 · 2024: 21 · 2023: 35 · 2022: 26 · 2021: 64 · 2020: 40 · 2019: 40 · 2018: 57 · 2017: 49 · 2016: 55 · 2015: 75 · 2014: 62 · 2013: 67 · 2012: 42
FWCI
39.06
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Breast Cancer Research Foundation
  • Pfizer
  • University of Michigan
  • National Institutes of Health
  • National Cancer Institute (CA101860, R01CA129765, CA-R01 129765, R01CA101860)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
anti-angiogenic therapy, breast cancer, cancer stem cells, tumor hypoxia, sunitinib, bevacizumab, hypoxia-inducible factor-1α, stem cell enrichment, metastasis, xenografts, combination therapy
MeSH terms
Sunitinib, Animals, Breast Neoplasms, Cell Count, Female, Humans, Indoles, Pyrroles, Neoplastic Stem Cells, Signal Transduction, Cell Hypoxia, Angiogenesis Inhibitors, Cell Line, Tumor, beta Catenin, Mice, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. https://app.cochat.ai/papers/10.1073/pnas.1018866109
The paper
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012). Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1018866109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.